Chemically modified heparin inhibits the in vitro adhesion of nonsmall cell lung cancer cells to P-selectin

Journal of Cancer Research and Clinical Oncology

Volumn 132, Issue 4, 2006, Pages 257-264

  Gao, Yanguang ^a   Wei, Min ^a   Zheng, Sheng ^a   Ba, Xueqing ^a   Hao, Shui ^a   Zeng, Xianlu ^a  

^a NORTHEAST NORMAL UNIVERSITY   (China)

Author keywords

Heparin; Modified heparin; Nonsmall cell lung cancer; P selectin; Platelet

Indexed keywords

HEPARAN SULFATE; HEPARIN; HEPARIN DERIVATIVE; HEPARIN LYASE; MONOCLONAL ANTIBODY; PADGEM PROTEIN; PROTEOHEPARAN SULFATE;

ANTICOAGULATION; ARTICLE; CANCER CELL; CELL ADHESION; CELL SURFACE; CHEMICAL MODIFICATION; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VITRO STUDY; LUNG NON SMALL CELL CANCER; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION;

ANIMALS; ANTINEOPLASTIC AGENTS; BLOOD PLATELETS; CARCINOMA, NON-SMALL-CELL LUNG; CELL ADHESION; CHO CELLS; CRICETINAE; CRICETULUS; DRUG EVALUATION, PRECLINICAL; HEPARIN; HUMANS; LUNG NEOPLASMS; NEOPLASM INVASIVENESS; P-SELECTIN; PROTEIN BINDING; TUMOR CELLS, CULTURED;

EID: 31344452160     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00432-005-0061-9     Document Type: Article

References (32)

1. Aruffo A, Dietch MT, Wan H, Hellstrom KE, Hellstrom I (1992) Granule membrane protein 140 (GMP140) binds to carcinomas and carcinoma-derived cell lines. Proc Natl Acad Sci USA 89:2292-2296
2. Biancone L, Araki M, Araki K, Vassalli P, Stamenkovic I (1996) Redirection of tumor metastasis by expression of E-selectin in vivo. J Exp Med 183:581-587
3. Borsig L, Wong R, Feramisco J, Nadeau DR, Varki NM, Varki A (2001) Heparin and cancer revisited: mechanistic connections involving platelets, P-selectin, carcinoma mucins, and tumor metastasis. Proc Natl Acad Sci USA 98:3352-3357
4. Borsig L, Wong R, Hynes RQ, Varki NM, Varki A (2002) Synergistic effects of L- and P-selectin in facilitating tumor metastasis can involve non-mucin ligands and implicate leukocytes as enhancers of metastasis. Proc Natl Acad Sci USA 99:2193-2198
5. Burdick MM, McCaffery JM, Kim YS, Bochner BS, Konstantopoulos K (2003) Colon carcinoma cell glycolipids, integrins, and other glycoproteins mediate adhesion to HUVECs under flow. Cell Physiol 284:C977-987
6. Dancey J, Le Chevalier T (1997) Non-small cell lung cancer: an overview of current management. Eur J Cancer 33(Suppl 1):S2-S7
7. Dardik R, Savion N, Kaufmann Y, Varon D (1998) Thrombin promotes platelet-mediated melanoma cell adhesion to endothelial cells under flow conditions: Role of platelet glycoproteins P-selectin and GPIIb-IIIa. Br J Cancer 77:2069-2075
8. Engelberg H (1999) Actions of heparin that may affect the malignant process.Cancer 85:257-272
9. X oligosaccharide. J Cell Biol 117:895-902
10. Frenette PS, Wagner DD (1997) Insights into selectin function from knockout mice. Thromb Haemost 78:60-64
11. Frenette FS, Denis CV, Weiss L, Jurk K, Subbarao S, Kehrel B, Hartwig JH, Vestweber D, Wagner DD (2000) P-Selectin glycoprotein ligand 1 (PSGL-1) is expressed on platelets and can mediate platelet-endothelial interactions in vivo. J Exp Med 191:1413-1422
12. Furie B, Furie BC (1995) The molecular basis of platelet and endothelial cell interaction with neutrophils and monocytes: role of P-selectin and the P-selectin ligand, PSGL-1. Thromb Haemost 74:224-227
13. Gould PM, Bonner JA, Sawyer TE, Deschamps C, Lange CM, Li H (1999) Patterns of failure and overall survival in patients with completely resected T3N0 non-small cell lung cancer. Int J Radiat Oncol Biol Phys 45:91-95
14. Handa K, Nudelman ED, Stroud MR, Shiozawa T, Hakomori SI (1991) Selectin GMP-140 (CD62; PADGEM) binds to sialosyl-Le(a) and sialosyl-Le(x), and sulfated glycans modulate this binding. Biochem Biophys Res Commun 181:1223-1230
15. Ichinose Y, Kato H, Koike T, Tsuchiya R, Fujisawa T, Shimizu N, Watanabe Y, Mitsudomi T, Yoshimura M (2001) Overall survival and local recurrence of 406 completely resected stage IIIA-N2 nonsmall cell lung cancer patients: questionnaire survey of the Japan Clinical Oncology Group to plan for a clinical trial. Lung Cancer 34:29-36
16. Jemal A, Thomas A, Murray T, Thun M (2002) Cancer Statistics. CA Cancer J Clin 52:23-47
17. Kansas GS (1996) Selectins and their ligands: current concepts and controversies. Blood 88:3259-3287
18. Karpatkin S, Pearlstein E (1981) Role of platelets in tumor cell metastases. Ann Intern Med 95:636-641
19. Kim YJ, Borsig L, Varki NM, Varki A (1998) P-selectin deficiency attenuates tumor growth and metastasis. Proc Natl Acad Sci USA 95:9325-9330
20. Kim YJ, Borsig L, Han HL, Varki NM, Varki A (1999) Distinct selectin ligands on colon carcinoma mucins can mediate pathological interactions among platelets, leukocytes, and endothelium. Am J Pathol 155:461-472
21. Koenig A, Norgard-Sumnicht K, Linhardt R, Varki A (1997) Differential interactions of heparin and heparan sulfate glycosaminoglycans with the selectins. Implications for the use of unfractionated and low molecular weight heparins as therapeutic agent. J Clin Invest 101:877-899
22. Kristiansen G, Schluns K, Yongwei Y, Denkert C, Dietel M, Petersen I (2003) CD24 is an independent prognostic marker of survival in nonsmall cell lung cancer patients. Br J Cancer 88:231-236
23. Lapierre F, Holme K, Lam L, Tressler RJ, Storm N, Wee J, Stack RJ, Castellot J, Tyrrell DJ (1996) Chemical modifications of heparin that diminish its anticoagulant but preserve its heparanase-inhibitory, angiostatic, anti-tumor and anti-metastatic properties. Glycobiology 6:355-366
24. Ma YQ, Geng JG (2000) Heparan sulfate-like proteoglycans mediate adhesion of human malignant melanoma A375 cells to P-selectin under flow. J Immunol 165:558-565
25. Mannori G, Crottet P, Cecconi O, Hanasaki K, Aruffo A, Nelson RM, Varki A, Bevilacqua MP (1995) Differential colon cancer cell adhesion to E-, P-, and L-selectin: Role of mucin-type glycoproteins. Cancer Res 55:4425-4431
26. McEver RP, Moore KL, Cummings RD (1995) Leukocyte trafficking mediated by selectin-carbohydrate interactions. J Biol Chem 270:11025-11028
27. Nash GF, Turner LF, Scully MF, Kakkar AK (2002) Platelets and cancer. Lancet Oncol 3:425-430
28. Stone JP, Wagner DD (1993) P-selectin mediates adhesion of platelets to neuroblastoma and small cell lung cancer. J Clin Invest 92:804-813
29. Varki NM, Varki A (2002) Heparin inhibition of selectin-mediated interactions during the hematogenous phase of carcinoma metastasis: rationale for clinical studies in humans. Semin Thromb Hemost 28:53-66
30. Wang L, Brown JR, Varki A, Esko JD (2002) Heparin's antiinflammatory effects require glucosamine 6-O-sulfation and are mediated by blockade of L- and P-selectins. J Clin Invest 110:127-136
31. Wei M, Tai G, Gao Y Li N, Huang BQ, Zhou Y, Hao S, Zeng X (2004) Modified heparin inhibits P-selectin-mediated cell adhesion of human colon carcinoma cells to immobilized platelets under dynamic flow conditions. J Biol Chem 279:29202-29210
32. Yoshitomi Y, Nakanishi H, Kusano Y, Munesue S, Oguri K, Tatematsu M, Yamashina I, Okayama M (2004) Inhibition of experimental lung metastases of Lewis lung carcinoma cells by chemically modified heparin with reduced anticoagulant activity. Cancer Lett 207:165-174